Valuation: BioNTech SE

Market Cap 20.52B 23.38B 19.11B 17.57B 32.94B 2,234B 33.51B 227B 88.72B 1,108B 87.77B 85.87B 3,827B P/E 2026 *
-18.5x
P/E 2027 * -17.8x
Enterprise Value 9.67B 11.02B 9B 8.28B 15.52B 1,052B 15.79B 107B 41.8B 522B 41.36B 40.46B 1,803B EV / Sales 2026 *
4.46x
EV / Sales 2027 * 5.04x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+1.49%
1 week+0.13%
Current month-0.64%
1 month+1.35%
3 months-9.42%
6 months-20.41%
Current year-2.89%
1 week 88.5
Extreme 88.5
92.71
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
12/5/26 Free

General Counsel

22,655 0.0094%
12/5/26 Free

Chief Operating Officer

22,655 0.0094%
12/5/26 Free

Chief Financial Officer

33,982 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
+1.49%+0.13%-18.03%-13.94% 23.38B
+0.13%+1.93%+50.27%+69.15% 55.01B
-1.32%-2.71%+34.27%+77.57% 54.24B
-0.57%-4.13%+2.34%+387.73% 22.57B
+2.07%+1.39%+17.20%-10.70% 20.19B
-0.55%-0.55%+29.55%-31.81% 17.86B
-2.14%-3.75%+26.23%+558.64% 15.5B
-6.69%-5.11%+169.13%+304.89% 14.2B
+1.25%+0.69%+27.30%+184.69% 14.2B
-2.26%-1.46%+83.17%+162.18% 12.42B
Average -0.86%-0.31%+42.14%+168.84% 24.96B
Weighted average by Cap. -0.60%-0.35%+37.50%+133.34%

Financials

2026 *2027 *
Net sales 2.17B 2.47B 2.02B 1.86B 3.48B 236B 3.54B 23.95B 9.37B 117B 9.27B 9.07B 404B 2.23B 2.54B 2.08B 1.91B 3.58B 243B 3.64B 24.64B 9.65B 120B 9.54B 9.34B 416B
Net income -1.04B -1.19B -972M -894M -1.68B -114B -1.71B -11.54B -4.52B -56.38B -4.47B -4.37B -195B -1.16B -1.33B -1.08B -998M -1.87B -127B -1.9B -12.87B -5.04B -62.88B -4.98B -4.87B -217B
Net Debt -10.85B -12.36B -10.1B -9.29B -17.42B -1,181B -17.72B -120B -46.92B -586B -46.41B -45.41B -2,024B -9.28B -10.58B -8.64B -7.95B -14.9B -1,010B -15.16B -103B -40.13B -501B -39.7B -38.85B -1,731B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
28/07/26 USD 92.45 +1.49% 679,283
27/07/26 USD 91.09 +1.97% 687,342
24/07/26 USD 89.33 -2.97% 886,104
23/07/26 USD 92.06 +0.25% 539,216
22/07/26 USD 91.83 -0.54% 508,360
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
81.13EUR
Average target price
107.04EUR
Spread / Average Target
+31.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock